Open Label Study to Assess the Efficacy, Safety and Dosing of Clevidipine in Pediatric Patients Undergoing Surgery
Phase of Trial: Phase IV
Latest Information Update: 20 Jun 2019
Price : $35 *
At a glance
- Drugs Clevidipine (Primary)
- Indications Perioperative hypertension
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms PIONEER
- Sponsors Chiesi Farmaceutici; Chiesi USA
- 12 May 2017 Planned End Date changed from 1 Feb 2016 to 1 Dec 2018.
- 12 May 2017 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2018.
- 12 May 2017 Status changed from recruiting to suspended.